Journal of Physiology & Pathology in Korean Medicine (동의생리병리학회지)

The Physiological Society of Korean Medicine and The Society of Pathology in Korean Medicine (대한동의생리학회·한의병리학회)
권호 표지

Acute Toxicity of Kami-Okchun-San in ICR-Mice

가미옥천산의 ICR 마우스 경구 투여에 의한 급성 독성시험 연구

  • Published : 2005.10.01
Download PDF
⟨ Previous Next ⟩

Abstract

Kami-Okchun-San(OCS) is known as an effective herbal medicine on Type 2 diabetes. We peformed to investigate acute toxicity of OCS on ICR mice. ICR mice in acute toxicity experiment were administered orally with dosages of 3,200mg/kg (low dosage group), 4,000mg/kg (middle dosage group), 5,000mg/kg (high dosage group) per single time, respectively. Body weights, clinical signs, motalities and histopathological finding were observed daily for 14 days according to the Regulation of Korean Food and Drug Administration(1999. 12. 22). Single oral administration of OCS with different dosages, no animals died of the test drug. Autopsy of animal revealed no abnormal gross findings. Therefore, LD50 value of OCS for ICR mice was more than 5,000mg/kg on oral route. Normally increasing changes were observed in body weight, drinking water and food intake in every dosage group. Hematological parameters were also observed normally in all animals. No histopathological lesions were observed in both control and treated animals. Above data suggest that no toxic dose level of OCS in ICR mice is considered to be more than 5,000mg/kg. Therefore, it was concluded that OCS have no effect on acute toxicity and side effect in ICR mice.

Keywords

References

  1. Taylor, S. I, Deconstructing Type 2 Diabetes. Cell 97(2):9-12, 1999. https://doi.org/10.1016/S0092-8674(00)80709-6
  2. 보건사회부. 국민영양조사보고서. 1969-1989.
  3. Yajnik, C. S. Nutrition, growth, and body size in relation to insulin resistance and type 2 diabetes. Curr. Diab. Rep. 3(2):108-114, 2003.
  4. Gerich, J. E, Contributions of insulin-resistance and insulin-secretory defects to the pathogenesis of type 2 diabetes mellitus. Mayo Clin. Proc. 78(4):447-456, 2003.
  5. Boden, G. Perspectives in diabetes. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 45, 3-10, 1996.
  6. 이광우. 새로운 당뇨병 치료제. 당뇨병 제21권 부록 2호 pp 39-45, 1997.
  7. 許浚. 東醫寶鑑. 南山堂, 서울. p 98, pp 140-142, 1990.
  8. 김종욱, 최용휴, 주영승, 박선민, 이미영, 김호경, 김홍준, 고병섭, 의이인이 3T3-L1 Adipocytes에서 인슐린성 작용과 인슐린 민감성에 미치는 영향. 대한한의학회지 23(1):83-91, 2002.
  9. 장문석, 진현선, 정계진, 박선민, 최수봉, 고병섭, 박성규. 4종 한약 처방이 db/db 마우스의 혈당 개선에 미치는 영향. 동의생리병리학회지 18(1):58-62, 2004.
  10. 박선민, 최미경, 전동화, 최수봉, 박성규, 이미영, 김호경, 황영희, 고병섭, 消渴 치료 處方 加減이 3T3-L1 Adipocytes에서 인술린 유사성과 인슐린 민감성에 미치는 영향. 동의생리병리학회지 18(2):451-456, 2004.
  11. 이영순, 조재진, 김영석, 남정석, 박재학, 이순복. 랫드와 마우스에서 DA-3030(G-CSF)의 급성독성에 관한 연구. 응용약물학회지 2, 256-259, 1994.